See All Slides - tctmd.com

Slides

Presentation TCT 2025

TCT 1484: CLEVE to the Rescue: Leveraging Innovation in Novel Leaflet Modification to Improve Patient Outcomes

Presenter: Dhiran Verghese

October 27, 2025

Presentation TCT 2025

TCT 290: Comparative Effectiveness of Milrinone and Dobutamine in Cardiogenic Shock: A Propensity-Matched Analysis of 6-Month and 1-Year Outcomes

Presenter: Junaid Mir

October 27, 2025

Presentation TCT 2025

In Intermediate-risk PE, What Measurable Improvements Can Catheter-Based Therapy Offer Over Anticoagulation??

Presenter: Suhail Dohad

October 27, 2025

Presentation TCT 2025

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

Presenter: Xiaochun Zhang

October 27, 2025

Presentation TCT 2025

Introduction to HyperVue and DeepOCT+NIRS Imaging

Presenter: Kevin J. Croce

October 27, 2025

Presentation TCT 2025

Reperfuse First and Avoid Bleeding

Presenter: Vijay Kunadian

October 27, 2025

Presentation TCT 2025

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

Presenter: Robert T. Gerber

October 27, 2025

Presentation TCT 2025

Tips and Tricks for Safe and Effective Closureof Coronaro-Structural Fistulas

Presenter: Carey D. Kimmelstiel

October 27, 2025

Presentation TCT 2025

Who’s the Right Patient? Interpreting Trials and Guidelines

Presenter: Matthew J. Price

October 27, 2025

Presentation TCT 2025

Featured Clinical Research: Pulmonary Hypertension–Based Risk Stratification for Transcatheter Tricuspid Interventions: A Harmonized, Practical Approach

Presenter: Karl-Philipp Rommel

October 27, 2025

Advertisement

Slides

TCT 1484: CLEVE to the Rescue: Leveraging Innovation in Novel Leaflet Modification to Improve Patient Outcomes

TCT 290: Comparative Effectiveness of Milrinone and Dobutamine in Cardiogenic Shock: A Propensity-Matched Analysis of 6-Month and 1-Year Outcomes

In Intermediate-risk PE, What Measurable Improvements Can Catheter-Based Therapy Offer Over Anticoagulation??

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

Introduction to HyperVue and DeepOCT+NIRS Imaging

Reperfuse First and Avoid Bleeding

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

Tips and Tricks for Safe and Effective Closureof Coronaro-Structural Fistulas

Who’s the Right Patient? Interpreting Trials and Guidelines

Featured Clinical Research: Pulmonary Hypertension–Based Risk Stratification for Transcatheter Tricuspid Interventions: A Harmonized, Practical Approach

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content